Eaton Vance Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.99M Hold
2022
Q2
$2.94M Hold
2022
Q1
$3.13M Hold
2021
Q4
$3.77M Sell
2021
Q3
$4.31M Hold
2021
Q2
$2.59M Buy
2021
Q1
$1.05M Buy